Plain-English translation of NCT07209358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new wound dressing system called EDX110 to see if it helps diabetic foot ulcers heal faster and better. You would be randomly assigned to either receive the new EDX110 dressing along with your usual wound care, or to continue with standard wound care alone. The study will follow your wound over time to compare how well each approach works.
Diabetic foot ulcers can be slow and difficult to heal, and some ulcers don't heal well even with standard treatments. Researchers believe this new dressing might help wounds close faster and more completely, which could prevent serious complications and improve quality of life.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: one receiving the new EDX110 dressing plus standard wound care, and the other receiving standard care only. You'll attend multiple clinic visits where your wound will be cleaned, measured, and photographed to track healing progress. The study will monitor your wound for several months, with regular check-ins to ensure the treatment is working and you're doing well.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States